Poland· PL-100517239
Spersallerg
A tetryzolin, kombinationen product containing antazolini hydrochloridum + tetryzolini hydrochloridum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tetryzolin, kombinationen is registered in 6 of 19 countries.
Countries holding a registration under ATC S01GA52 (tetryzolin, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Tetryzolin, kombinationen · ATC S01GA52
6 / 19 countries
- Canada
- Czechiaprice
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Antazolini hydrochloridum + Tetryzolini hydrochloridum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- S01GA52
- ATC class
- Tetryzolin, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991571290
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tetryzolin, kombinationen in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandSpersallerg SDU, Collyre en solution en récipient unidoseTHEA Pharma S.A.
- CzechiaSPERSALLERGLaboratoires Thea, Clermont-Ferrand
- NorwaySpersallergThéa
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Bulgaria · Сперсалерг
- Czechia · Spersallerg
- Norway · Spersallerg
- Romania · Spersallerg
- Slovenia · Spersallerg
- Slovakia · Spersallerg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0bd3c06e-1654-4ce4-bf7e-e3d84f6839c3 GET /v1/drugs/0bd3c06e-1654-4ce4-bf7e-e3d84f6839c3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "(0,5 mg + 0,4 mg)/ml",
"packaging": "05909991571290 ¦ Rp ¦ 161550\n1 butelka 10 ml",
"substance": "Antazolini hydrochloridum 0.5 mg/ml + Tetryzolini hydrochloridum 0.4 mg/ml",
"common_name": "Antazolini hydrochloridum + Tetryzolini hydrochloridum",
"pl_product_id": "100517239",
"pozwolenie_nr": "147/25",
"auth_procedure": "IR",
"authorisation_validity": "2030-04-24"
}See everything about tetryzolin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.